Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies

Clinical trial NCT02543879 · COMPLETED

Trial details

NCT number: NCT02543879
Sponsor: Forma Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myelogenous Leukemia Myelodysplastic Syndrome Non-Hodgkin Lymphoma

Start date: 2015-09-01
Primary completion: 2019-03-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.